No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
Established in 1990 in New Taipei City, Taiwan, Wellell Inc. is a global enterprise active in the medical supplies sector. The company's activities span research and development, manufacturing, and the international distribution (import, export, and sales) of its diverse product portfolio. This includes items for wound care, respiratory therapy devices, assistive welfare equipment, and other electronic medical instruments. Wellell's specific offerings feature pressure relief mattresses and seating, as well as advanced solutions for sleep apnea, such as auto-adjusting pressure systems and their Sleepwell product line. These innovative solutions primarily focus on the prevention of pressure injuries and the management of obstructive sleep apnea.
www.wellell.com/enNo one on the platform currently holds 4106.TW.
No tracked institution reports a position in 4106.TW as of their last filing.
No one on the platform has traded 4106.TW yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 5.5% | 6.0% | 5.8% | — | — | — |
| Rev. Growth % | 0.7% | 3.7% | ||||
| Profit Margin % | 5.0% | 5.2% | 5.2% | |||
| Free Cash Flow Margin % | 6.4% | 5.7% | 6.1% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $2.2B | — | $1.68 | $1.68–$1.68 | — | 1 |
| 2028 | $2.0B | -11.4% | $1.01 | $1.01–$1.01 | — | 1 |
| 2029 | $2.0B | +0.0% | $1.01 | $1.01–$1.01 | — | 1 |
| 2030 | $2.4B | +20.0% | $1.24 | $1.24–$1.24 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 3 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-05 | $0.31 | $0.63 | +103.2% |
| 2026-08-04 | $0.31 | $0.46 | +48.4% |
| 2026-03-10 | $0.07 | $0.28 | +300.0% |
| -0.22% |
| $1.3B |
| — |
| 4175.TWOMedFirst Healthcare Services, Inc. | $51.50 | +0.00% | $2.2B | — |
| 6527.TWOCrystalvue Medical Corporation | $75.20 | +0.27% | $1.9B | — |
Source: Financial Modeling Prep · peers by sector/industry